From global pharmaceutical leaders to innovative Montana-based companies, our partners strengthen and accelerate the state’s bioscience ecosystem. Through collaboration, investment, research, and advocacy, these organizations help drive discovery, expand opportunity, and improve lives across Montana and beyond.
Montana’s bioscience momentum is built on collaboration. Our partners represent world-class research institutions, global biopharmaceutical companies, emerging innovators, healthcare providers, and strategic investors committed to advancing science and strengthening communities. Together, we expand access to innovation, support responsible policy, fuel economic growth, and ensure Montana remains a nationally competitive hub for bioscience excellence.

The Advanced Medical Technology Association (AdvaMed) is the leading trade association representing medical device, diagnostic, and health technology manufacturers. AdvaMed advocates for public policies that support innovation, patient access, and a competitive regulatory environment, with a focus on improving healthcare delivery through responsible innovation. By uniting the industry’s voice in state and federal policy discussions, AdvaMed strengthens the ecosystem that enables medical breakthroughs.

Avantor Sciences is a global provider of mission-critical products and services that support the entire scientific research and production lifecycle. From advanced lab supplies and equipment to tailored solutions for biopharma, biotechnology, and life sciences, Avantor enables scientists and researchers to accelerate discovery and improve outcomes. With a commitment to safety, sustainability, and innovation, Avantor partners with organizations worldwide to elevate scientific progress.

PhRMA represents America’s leading biopharmaceutical research companies dedicated to discovering and developing medicines that improve patient health and quality of life. As an advocate for public policies that support innovation, patient access, and a predictable regulatory environment, PhRMA brings together scientific expertise and industry leadership to advance groundbreaking therapies and strengthen the healthcare ecosystem. Through policy research, stakeholder engagement, and collaborative partnerships, PhRMA works to enable research investment and enable treatments that benefit people in Montana and around the world.

CSBio designs and manufactures automated peptide synthesizers and oligonucleotide synthesizers used in laboratories, research institutions, biotech companies, and pharmaceutical production worldwide. With decades of industry leadership, CSBio’s instrumentation supports peptide and DNA synthesis from research scale to commercial applications.

CubCloud AI is a Montana-rooted technology ecosystem uniting AI software innovation, data-center infrastructure, and community investment. Focused on building sovereign AI infrastructure, CubCloud provides high-performance compute, custom AI solutions, and research support while reinvesting in local industries, education, and community causes.

Genentech, a member of the Roche Group, is a pioneering biotechnology company advancing groundbreaking science to discover and develop potential new medicines for serious and life-threatening diseases. Its research focuses on transforming scientific discoveries into therapeutic solutions with the goal of improving patient outcomes worldwide.

GRAIL is a biotechnology company dedicated to reducing the global burden of cancer through next-generation sequencing and machine-learning-enhanced detection technologies. Its flagship Galleri® test aims to detect many types of cancer early, when treatment may be more effective.

GSK is a global biopharmaceutical company committed to uniting science, technology, and talent to tackle major health challenges. With research focused on respiratory, immunology, oncology, HIV, and infectious diseases, GSK aims to positively impact billions of lives through innovative medicines and vaccines.

Inimmune is a clinical-stage biotechnology company developing innovative immunotherapies and vaccine adjuvants that harness the human immune system to prevent and treat disease. Based in Missoula, Montana, Inimmune’s research and development focus on next-generation therapeutics for allergy, infection, autoimmunity, and cancer.

Johnson & Johnson is one of the world’s largest healthcare companies, delivering a broad portfolio of pharmaceuticals, medical devices, and consumer health products. With a global presence, J&J develops treatments and technologies across therapeutic areas, advancing care and improving health outcomes worldwide.

Merck is a leading global healthcare company that follows the science to develop critical medicines and vaccines. Its work spans clinical trials, patient assistance programs, and initiatives to improve public health and access to care, addressing some of the world’s toughest health challenges.

Shodair is a nonprofit healthcare organization dedicated to improving children’s mental health through clinical services, research, and family support programs. Based in Montana, Shodair’s integrated care model emphasizes community outreach, education, and evidence-based treatment for youth and families.

Two Bear Capital is an investment firm that partners with innovative life-science companies to accelerate growth and impact. With strategic backing and industry expertise, Two Bear Capital supports ventures like Inimmune that are advancing breakthroughs in immunotherapy, vaccines, and human health technologies.

Advancing a connected, competitive bioscience ecosystem for Montana’s people, communities, and economy.
© Copyright 2026 | Privacy Policy | Terms of Service | Website & CRM by LocationSync